I-SPY 2 Trial Sites
The University of California, San Francisco is currently the only trial site that is open and accruing patients. See below for a full list of sites in the pipeline to open in the next year.
Current I-SPY 2 Site Locations:
Prospective I-SPY 2 Site Locations:
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
- University of Minnesota Medical Center, Minneapolis, MN
- Moores Cancer Center, University of California, San Diego, La Jolla, CA
- The University of Texas MD Anderson Cancer Center, Houston, TX
- University of Colorado Cancer Center, Aurora, CO
- Mayo Clinic, Scottsdale, AZ
- Mayo Clinic, Rochester, MN
- OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR
- Inova Health System, Falls Church, VA
- Swedish Cancer Institute, Swedish Medical Center, Seattle, WA
- The University of Chicago Cancer Research Center, Chicago, IL
- The Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
- The USC/Norris Comprehensive Cancer Center, The University of Southern California, Los Angeles, CA
- Winship Cancer Institute of Emory University, Atlanta, GA
- The Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
- The University of Kansas Cancer Center, Kansas City, KS
- Arizona Cancer Center, The University of Arizona, Tucson, AZ
- Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
- Cardinal Bernardin Cancer Center, Loyola University Health System, Maywood, IL
- UAB Comprehensive Cancer Center, University of Alabama, Birmingham, AL
- The BC Cancer Agency, Vancouver, BC
